- Home
- AXSM vs HOMB Comparison
AXSM vs HOMB Comparison
Compare AXSM & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- HOMB
- Stock Information
- Founded
- AXSM 2012
- HOMB 1998
- Country
- AXSM United States
- HOMB United States
- Employees
- AXSM N/A
- HOMB N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- HOMB Major Banks
- Sector
- AXSM Health Care
- HOMB Finance
- Exchange
- AXSM Nasdaq
- HOMB Nasdaq
- Market Cap
- AXSM 5.1B
- HOMB 5.0B
- IPO Year
- AXSM 2015
- HOMB 2006
- Fundamental
- Price
- AXSM $105.71
- HOMB $29.60
- Analyst Decision
- AXSM Strong Buy
- HOMB Hold
- Analyst Count
- AXSM 16
- HOMB 5
- Target Price
- AXSM $170.50
- HOMB $31.00
- AVG Volume (30 Days)
- AXSM 694.5K
- HOMB 883.6K
- Earning Date
- AXSM 08-04-2025
- HOMB 07-16-2025
- Dividend Yield
- AXSM N/A
- HOMB 2.72%
- EPS Growth
- AXSM N/A
- HOMB 8.29
- EPS
- AXSM N/A
- HOMB 2.09
- Revenue
- AXSM $432,157,000.00
- HOMB $987,214,000.00
- Revenue This Year
- AXSM $62.84
- HOMB $11.25
- Revenue Next Year
- AXSM $60.02
- HOMB $2.78
- P/E Ratio
- AXSM N/A
- HOMB $13.70
- Revenue Growth
- AXSM 72.16
- HOMB 1.15
- 52 Week Low
- AXSM $72.21
- HOMB $23.23
- 52 Week High
- AXSM $139.13
- HOMB $32.91
- Technical
- Relative Strength Index (RSI)
- AXSM 48.53
- HOMB 54.17
- Support Level
- AXSM $99.75
- HOMB $28.03
- Resistance Level
- AXSM $106.60
- HOMB $28.83
- Average True Range (ATR)
- AXSM 3.11
- HOMB 0.45
- MACD
- AXSM 0.10
- HOMB 0.07
- Stochastic Oscillator
- AXSM 44.39
- HOMB 70.76
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.